top of page

2013 News Archives

FDA MALARIA GUIDANCE UPDATE PUBLISHED

December 5, 2013

The FDA guidance update to the malaria risk maps collection has been completed and is now in production. Updates will be shipped automatically to subscription clients. Order forms have been distributed to all current non-subscription clients. 

Final hard copy pricing for this update is:

Screening Editions – Malaria Only: $87 – Malaria & vCJD: $90

Reference Editions – Malaria Only: $100 – Malaria & vCJD: $103

Electronic version pricing will be included on your order form if applicable.

This update includes the following:

Redesigned and revised reference lists:

Malaria-Endemic Countries (for screening residents)

Countries with Malaria-Endemic Areas (for screening travelers)

Countries With vCJD Risk (vCJD editions only)

Non-Malaria Endemic Countries, Dependencies, and Areas of Special Sovereignty

Ports of Call of the Caribbean, Mexico, Central America, & South America

16 revised maps

1 new overlay & 3 revised overlays

Revised location indexes for Mexico and China

Revised Technical Notes (Reference editions only)

Revised Document Change History

Set of additional index dividers to organize new and existing content

FDA ISSUES FINAL GUIDANCE ON MALARIA
August 20, 2013

The FDA's memorandum to all registered blood establishments entitled “Recommendations for Deferral of Donors for Malaria Risk” dated July 26, 1994 has been superceded by a new guidance document entitled "Guidance for Industry: Recommendations for Donor Questioning, Deferral, Reentry and Product Management to Reduce the Risk of Transfusion-Transmitted Malaria".

 

http://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Blood/ucm365191.htm

bottom of page